Canoan 30 mg (Nisergoldin)

Adult dose

* 5, 10mg Adults: Administer 5~10mg of nicergoline orally 2~3 times daily before meals. Adjust the dose as appropriate according to symptoms. * 30mg Adults: Administer 30 mg of nicergoline orally once daily before a meal. If the desired effect is not achieved at this dose, it may be increased to 60 mg. The dose may be reduced after symptoms improve. Reduce the dose in patients with impaired renal function (serum creatinine >175 µmol/L) (2 mg/dL).

This medication should not be used in certain patients. For example, those who have had allergic reactions to this medication or ergot alkaloids should not take it. Additionally, patients with acute myocardial infarction or acute bleeding, those taking sympathomimetic agents, patients with very slow heart rates (bradycardia), those who have had intracranial hemorrhage without completed hemostasis, and those with postural control disorders should also avoid using this medication. Patients with mild bradycardia or impaired renal function should use this medication cautiously. When taking this medication, gastrointestinal symptoms such as decreased appetite, diarrhea, constipation, nausea, vomiting, abdominal pain, and dry mouth may occur rarely. Liver function test values may increase. In the cardiovascular system, dizziness, orthostatic hypotension, hypertension, increased serum uric acid levels, and decreased blood pressure can occur. In the mental and neurological system, symptoms such as drowsiness, fatigue, headache, insomnia, and tinnitus may appear rarely. Hypersensitivity may lead to skin rashes, itching, hives, flushing, and a feeling of heat. Taking this medication with other antihypertensive drugs may cause blood pressure to become too low, so blood pressure should be checked frequently. It may affect uric acid metabolism, so patients with gout or hyperuricemia should be cautious. After taking this medication, driving or operating machinery requires caution. This medication is metabolized in the liver, so there may be interactions with other drugs that affect liver metabolism. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and breastfeeding mothers should avoid taking it or discontinue breastfeeding, if possible. Elderly patients may have decreased bodily functions, so dosage adjustments and caution are needed. Safety in children has not yet been established. In case of overdose, blood pressure may temporarily drop, so blood pressure changes should be closely monitored, and appropriate measures should be taken. This medication should be kept out of reach of children, and it is important to store it in its original container and seal it securely.

Loss of appetite, diarrhea, constipation, nausea, vomiting, nonspecific upper abdominal pain or cramping, thirst, elevated ALT, elevated AST, dizziness, orthostatic dysregulation, hypertension, increased blood uric acid, hypotension, drowsiness, fatigue, headache, tinnitus, exhaustion, insomnia, rash, urticaria, itching, flushing, heat sensation, nightmares, mood disturbances, dyspepsia

This medication is sensitive to light, so it should be stored in a light-protected container. It should also be kept in a sealed container to avoid exposure to air, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Yellow round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle